Cargando…

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

Timely vaccine supply is critical during influenza pandemics but is impeded by current virus-based manufacturing methods. The 2009 H1N1/2009pdm ‘swine flu’ pandemic reinforced the need for innovation in pandemic vaccine design. We report on insights gained during rapid development of a pandemic vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honda-Okubo, Yoshikazu, Rajapaksha, Harinda, Sajkov, Dimitar, Gordon, David, Cox, Manon M. J., Petrovsky, Nikolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489286/ https://www.ncbi.nlm.nih.gov/pubmed/28301280 http://dx.doi.org/10.1080/21645515.2017.1279765

Ejemplares similares

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
por: Li, Lei, et al.
Publicado: (2015)

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2021)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015)

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
por: Komiya, Tomoyoshi, et al.
Publicado: (2021)

Alzheimer’s disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
por: Davtyan, Hayk, et al.
Publicado: (2016)

In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies
por: Rajapaksha, Harinda, et al.
Publicado: (2014)

Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
por: Li, Lei, et al.
Publicado: (2022)

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2023)

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
por: Wanandy, Troy, et al.
Publicado: (2019)

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
por: Lobigs, Mario, et al.
Publicado: (2010)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
por: Ferrell, Kia C., et al.
Publicado: (2021)

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
por: Bielefeldt-Ohmann, Helle, et al.
Publicado: (2014)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
por: Li, Lei, et al.
Publicado: (2021)

Two Types of Antibodies Are Induced by Vaccination with A/California/2009pdm Virus: Binding near the Sialic Acid-Binding Pocket and Neutralizing Both H1N1 and H5N1 Viruses
por: Ohshima, Nobuko, et al.
Publicado: (2014)

Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
por: Vasan, Sandhya, et al.
Publicado: (2010)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
por: Wijnans, Leonoor, et al.
Publicado: (2017)

Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness
por: Cao, Lirong, et al.
Publicado: (2021)

Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy
por: Heddle, Robert, et al.
Publicado: (2013)

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study
por: Roy-Ghanta, Sumita, et al.
Publicado: (2014)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
por: Vasan, S, et al.
Publicado: (2009)

Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009
por: Mörner, Andreas, et al.
Publicado: (2012)

Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns
por: Helmig, Rikke B., et al.
Publicado: (2015)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Myocarditis Associated with Influenza A H1N1pdm2009
por: Ukimura, Akira, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gcucmol3mi5bcq1ohmaenb2p8m